DL
CL icon

Daniel Loeb’s Colgate-Palmolive CL Stock Holding History

Daniel Loeb’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,050,000
Closed -$830M – 46
2023
Q1 		$830M Sell
11,050,000
-500,000
-4% -$37.2M 13.59% 2
2022
Q4 		$910M Hold
11,550,000
– – 15.25% 2
2022
Q3 		$811M Buy
11,550,000
+9,565,000
+482% +$750M 14.66% 1
2022
Q2 		$159M Buy
+1,985,000
New +$155M 3.77% 8

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Daniel Loeb's CL Position: Q2 2023 in Review

Daniel Loeb sold out of Colgate-Palmolive (CL) in Q2 2023, closing a stake of 11,050,000 shares — an estimated $830M sold.

Daniel Loeb first reported a position in CL in Q2 2022 and held it in 4 quarters. The position peaked at $910M in Q4 2022. 1,680 funds tracked by Wall St. Rank hold CL as of Q2 2023.

  • Daniel Loeb reported no remaining Colgate-Palmolive position as of Q2 2023 after selling out during the quarter.
  • Daniel Loeb sold 11,050,000 Colgate-Palmolive shares in Q2 2023, an estimated $830M.
  • Daniel Loeb first reported a position in Colgate-Palmolive in Q2 2022 and held it in 4 quarters.
  • Daniel Loeb's Colgate-Palmolive position peaked at $910M in Q4 2022.
  • 1,680 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2023.

Based on Third Point's 13F filing for Q2 2023, filed 14 Aug 2023.